Labixiaoxin Snacks Group Limited reported that both its authorised and issued share capital were unchanged during April 2026.

• Authorised capital stood at 500.00 million ordinary shares with a par value of USD 0.001 each, maintaining an authorised share capital of USD 0.50 million.

• Issued share capital remained steady at 239.25 million ordinary shares, all of which are listed on the Hong Kong Stock Exchange. The company held no treasury shares at month-end.

• The board confirmed compliance with the Main Board’s minimum public-float requirement of 25%, indicating sufficient free-float after month-end.

• Under the share option scheme approved on 23 June 2021, no options were exercised or granted in April. The scheme still allows for the future issuance of up to 13.29 million shares.

• The company reported no outstanding warrants, convertible securities, or other equity-linked instruments, and no other share movements occurred during the month.

Overall, Labixiaoxin Snacks’ equity structure remained stable in April 2026 with no capital adjustments and full adherence to Hong Kong listing requirements.